Title

FY24 Annual Results

  • Revenue

    $1,186.0M

  • Y-o-Y Revenue Growth

    +14.5%

  • PAT

    ₹10.9B

  • Y-o-Y EBITDA

    13.5%

Q4 FY24 Quarterly Results

  • Revenue

    $310.9M

  • Q-o-Q Revenue Growth

    +3.4%

  • Y-o-Y Revenue Growth

    +13.2%

  • PAT

    ₹3.2B

Consolidated Financial Highlights for the Financial Year 2023-2024:

FY23 FY24 Y-o-Y Growth
Revenue (USD Million) 1,035.98 1,186.05 14.5%
Revenue (INR Million) 83,505.92 98,215.87 17.6%
EBITDA (INR Million) 15,191.25 17,243.02 13.5%
PBT (INR Million) 12,408.52 14,476.06 16.7%
PAT (INR Million) 9,210.93 10,934.92 18.7%

Consolidated Financial Highlights for the Quarter ended March 31, 2024:

Q4 FY24 Q-o-Q growth Y-o-Y growth
Revenue (USD Million) 310.89 3.4% 13.2%
Revenue (INR Million) 25,905.26 3.7% 14.9%
EBITDA (INR Million) 4,543.62 2.8% 9.1%
PBT (INR Million)  3,954.93 1.6% 16.1%
PAT (INR Million) 3,153.22 10.2% 25.4%
Persistent Leadership Quote Option 1
Dr. Anand Deshpande, Founder, Chairman and Managing Director
Our continued success this fiscal year is a testament to our innovative spirit, remarkable resilience, and strategic foresight, powering the digital transformation journeys of our clients. We approach every challenge as an opportunity and every achievement as a stepping-stone for future endeavors. Our determination to excel in everything we do has helped us set new benchmarks in the industry. We will continue to push the boundaries to scale new heights in the coming year.

Anand Deshpande, Founder, Chairman and Managing Director, Persistent

Persistent Leadership Quote Option 2
Sandeep Kalra, Chief Executive Officer and Executive Director, Persistent
As we reflect on fiscal year 2024, I would like to extend my gratitude towards our incredible team, clients, partners, and investors, whose continued trust has powered our impressive journey.
Our industry-leading growth, strong operational rigor, and commitment to building differentiated capabilities led to Persistent’s recognition as the “Most Promising Company” of the Year by CNBC-TV18 at the 2023 India Business Leader Awards. We were also included in three prestigious capital market indices – MSCI India Index, S&P BSE 100, and S&P BSE SENSEX Next 50.
As we enter the new fiscal year, we are confident in our ability to drive sustainable growth with strategic investments in disruptive technologies like AI and are excited about the road ahead.

Sandeep Kalra, Chief Executive Officer and Executive Director, Persistent

Fourth Quarter FY24 Client Wins and Outcomes

Software, Hi-Tech, & Emerging Industries

  • Spearheading IT transformation initiatives, including upgrading legacy middleware stack to open-source and developing AI/ML applications for a leading consumer intelligence company
  • Enabling open-source software porting and validation to support large data volume for a key cloud infrastructure offering for one of the largest global technology companies
  • Setting up an offshore research and development center for the core energy control system for one of the largest European conglomerates

Banking, Financial Services & Insurance

  • Accelerating digital transformation and automation as well as engineering a GenAI platform for a leading insurance distribution and risk management firm
  • Driving new CRM experiences including workflow automation for sales, contact center, and marketing for the financial services arm of a Fortune 500 automobile company
  • Building next-generation banking platform for neo-banks and building societies leveraging Digital Engineering capabilities for a leading UK-based FinTech

Healthcare & Life Sciences

  • Developing a modern data and analytics platform in collaboration with one of the largest data warehousing firms and a leading hyperscaler for a drug wholesaler and contract research organization
  • Migrating clinical applications to a unified cloud platform and integrating them with electronic medical record applications for a leading renal care service provider
  • Building a centralized patient relationship management system to enhance patient care and operational efficiency for a leading biopharmaceutical company
Quarterly Results for FY 2023-24
Fourth Quarter Ended March 31, 2024
Third Quarter Ended December 31, 2023
Second Quarter Ended September 30, 2023
First Quarter Ended June 30, 2023

Previous Quarterly Results

Financials Results – FY2019-20

Downlaod the Quarterly Results

Financials Results – FY2018-19

Downlaod the Quarterly Results

Financials Results – FY2017-18

Downlaod the Quarterly Results

Financials Results – FY2016-17

Downlaod the Quarterly Results

Financials Results – FY2015-16

Downlaod the Quarterly Results

Financials Results – FY2014-15

Downlaod the Quarterly Results

Contact us

(*) Asterisk denotes mandatory fields

    You can also email us directly at info@persistent.com

    You can also email us directly at info@persistent.com